This chapter reviews the pharmacotherapy for pulmonary arterial hypertension (PAH) based on the 2022 European Society of Cardiology/European Respiratory Society and 2019 CHEST guidelines.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Pulmonary Arterial Hypertension (Group 1 Pulmonary Hypertension)

  • Jennifer Pai Lee

摘要

This chapter reviews the pharmacotherapy for pulmonary arterial hypertension (PAH) based on the 2022 European Society of Cardiology/European Respiratory Society and 2019 CHEST guidelines.